ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,281.60
      -0.27%
      Dow Jones
      42,063.36
      0.09%
      Brent Oil
      74.135
      -0.25%
      Bitcoin
      63,182.68
      0.37%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cortexyme Inc (CRTX) Quote

      Cortexyme Inc

      Cortexyme Inc (CRTX)

      Crism Therapeutics Corporation
      1.95
      0.00
      (0.00%)
      At close: September 20 4:00PM
      Delayed by 15 minutes
      1.95
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.95
      Bid
      1.91
      Ask
      1.99
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      83.595M
      Previous Close
      1.95
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      42,869,000
      Dividend Yield
      -
      PE Ratio
      -1.16
      Earnings Per Share (EPS)
      -0.73
      Revenue
      -
      Net Profit
      -31.39M

      About Cortexyme Inc

      Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic vi... Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      quincetx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      CRTX Latest News

      More News

      Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010

      CARY, N.C., Dec. 18 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      December 18 2009
      PR Newswire (US)

      Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal

      CARY, N.C., Nov. 20 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      November 20 2009
      PR Newswire (US)

      Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference

      CARY, N.C., Nov. 16 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      November 16 2009
      PR Newswire (US)

      Cornerstone Therapeutics Appoints General Counsel

      CARY, N.C., Nov. 13 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      November 13 2009
      PR Newswire (US)

      Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results

      CARY, N.C., Nov. 4 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      November 04 2009
      PR Newswire (US)

      Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call

      CARY, N.C., Oct. 21 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      October 21 2009
      PR Newswire (US)

      Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)

      CARY, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      September 03 2009
      PR Newswire (US)

      Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences

      CARY, N.C., Sept. 3 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      September 03 2009
      PR Newswire (US)

      Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal

      CARY, N.C., July 20 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing products...

      July 20 2009
      PR Newswire (US)

      Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product

      CARY, N.C., July 15 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (NASDAQ:CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant...

      July 15 2009
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      JSPRWJasper Therapeutics Inc
      $ 0.3333
      (66.65%)
      		202
      TGLTreasure Global Inc
      $ 1.10
      (61.69%)
      		2.75M
      NUKKNukkleus Inc
      $ 0.29
      (36.47%)
      		10.84M
      ULYUrgent ly Inc
      $ 1.15
      (30.37%)
      		7.73M
      GGRGogoro Inc
      $ 0.6077
      (17.79%)
      		3.63k
      PRFXPainReform Ltd
      $ 0.5725
      (-25.76%)
      		316.67k
      ZJYLJin Medical International Ltd
      $ 3.17
      (-22.30%)
      		226.8k
      FRESFresh2 Group Ltd
      $ 1.43
      (-17.34%)
      		14.2k
      ADTXAditxt Inc
      $ 0.3258
      (-14.85%)
      		6.1M
      INMInMed Pharmaceuticals Inc
      $ 0.2268
      (-14.38%)
      		45.17k
      NVDANVIDIA Corporation
      $ 116.06
      (0.05%)
      		13.98M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.088
      (-3.83%)
      		11.1M
      NUKKNukkleus Inc
      $ 0.29
      (36.47%)
      		10.84M
      XPONExpion360 Inc
      $ 0.0765
      (-9.79%)
      		10.62M
      INTCIntel Corporation
      $ 21.9501
      (0.50%)
      		8.22M

      Discussion

      View Full Feed
      ccie1024 ccie1024 2 minutes ago
      Bring it!
      NWBO
      SCAMBUSTERKING SCAMBUSTERKING 2 minutes ago
      Keep loading 😂☠️😂☠️😂☠️
      BCAP
      BADALI BADALI 3 minutes ago
      Show me if you post any your original DD on IGPK ?
      Show me who others I posted all time Twitter DD ?
      IGPK
      PEACHMAN PEACHMAN 4 minutes ago
      The total volume was less than 30,000 shares Kitty...Longs are not dumping millions of shares like you guaranteed..kitty.

      IFUS longs are holding their investment in IFUS for the long term


      IFUS STRONG
      IFUS
      dreamaker56 dreamaker56 5 minutes ago
      "If you get any clue" what kind of English is that? 🤣

      Go $IGPK
      IGPK
      Whale Gunna Whale Gunna 5 minutes ago
      Bidding .0006
      ADHC
      I ll be back I ll be back 5 minutes ago
      Steal, I thought you were smarter than this.

      Yeah I saw that as well that this company has a lawsuit against them. Hopefully volume can come in enough to get out before this thing crashes to nothing. You are right. ITYS this is a SCAM!

      Really, the suit you are referring
      MGON
      Lime Time Lime Time 5 minutes ago
      CEO is young. It's a lifetime investment. It will run up huge from this price, that's guaranteed. I wish there were more OTC CEOs that would do this 🚀

      The more, the merrier
      BCAP
      TheRealMrPirate TheRealMrPirate 6 minutes ago
      Tell everyone you have no clue without yelling it out. The company hasn't been a legal entity in over 6 years. I know that doesn't register with you, oh well, so be it.
      Good for Continental, they had nothing to do with former BioAmber and you haven't acknowledged the basics yet.
      Good l
      dreamaker56 dreamaker56 6 minutes ago
      Speaking of him, surprised we haven't seen him show up.
      IGPK
      klonerpride klonerpride 6 minutes ago
      Nice Try Jane! As Marky Marc would say Enthusiastically yours @ Dukes of Malibu!
      KNOS
      JusDePomme JusDePomme 7 minutes ago
      Nothing to worry if u can buy .0003 here on....risk losing very low at this point!
      AAPJ
      dreamaker56 dreamaker56 7 minutes ago
      Ok buddy, if you say so. Keep reposting other peoples posts because that's all you have. I'm pro IGPK, always have been but very critical. You seem to miss that with all your insults to me.
      IGPK
      theorysuit theorysuit 7 minutes ago
      Please just stop, you are embarrassing. I know you are getting paid, but still bro.
      NWBO
      dreamaker56 dreamaker56 9 minutes ago
      Exactly, but needless to say it's been a great week here at IGPK
      IGPK
      ChannelTrader ChannelTrader 9 minutes ago
      You know she's for Trump ?
      This is a Pro TRUMP Board
      OMOLIVES OMOLIVES 10 minutes ago
      Exactly. Embezzlement would be a blessing if that were the case. It's unfortunately worse.
      mr_sano mr_sano 10 minutes ago
      Does it matter? They will not come close. Remember these idiots are dangling nonbinding LOI and MOU garbage like they have done a dozen times before.

      Remember successful companies preform then they release the news. When you are sucky little troll company looking to keep fleecing inv
      QSEP
      saturn_five saturn_five 11 minutes ago
      RSLS ; Reverse split ( share consolidation ) at 1:58 ratio.
      Looks like Monday 9/23/24 is effective date for R/S AND merger ...
      New ticker = HIND (NASDAQ)
      HIND = VYOME THERAPEUTICS , HQ in Cambridge, MA, ( Boston )
      ( Cambridge is home to both Harvard and M.I.T. )
      Fr
      RSLS
      BIOCHEMUP BIOCHEMUP 11 minutes ago
      Another rocket successfully deployed 🚀
      RKLB
      otterman otterman 11 minutes ago
      Linda always has to be right, especially when the lies supporting the company come tumbling down.

      Now I kinda remember when they were trying to launch into the music industry that there were some others put in charge of some things so maybe thats what shes trying to spout off on witho
      DBMM
      Its_TradingG Its_TradingG 11 minutes ago
      Docsetc loves Chandra, hint hint! Chandra please put out an Adnexus PR!

      https://x.com/supertabra55141/status/1837237384574111836?s=46

      $2000 in favor of Chandra ignoring him like always lol. Do not be fooled

      Docs - You're being documented, be very careful
      ENZC
      Investor082 Investor082 12 minutes ago
      The more these pumpers post non sense, the more it becomes clear that you don't want to be a bagholder after UK approval spike!
      NWBO
      joe botts joe botts 13 minutes ago
      I called , they had me on hold for quite awhile. I gave up after 20 minutes. Will try again , Monday.
      TONR

      Your Recent History

      NASDAQ
      CRTX
      Cortexyme
      Delayed Upgrade Clock